Tagged with Pharma

Thailand The Pharmaceutical Research and Manufacturers Association (PReMA) has been a key stakeholder in promoting the value of innovation in Thailand for over 100 years. CEO Dr Busakorn Lerswatanasivalee discusses the changes taking place in the Thai healthcare ecosystem and highlights the key initiatives undertaken by PReMA to widen access to,…

Pfizer Selim Sezgin, country manager and managing director of Pfizer Thailand, highlights the recent transformation of the affiliate to adapt to Thailand’s changing climate, as well as the vision of Pfizer in driving impactful partnerships with government and medical stakeholders to drive innovation access for Thai patients.   Pfizer’s new tagline…

Sweden Swedish firm Orexo AB, despite its relatively small stature, is playing a major role in combating one of the USA’s biggest public health emergencies – the opioid crisis.   Orexo, most widely known for its opioid dependence drugs, was founded in 1995 in Uppsala, Sweden. Its top-selling product is Zubsolv,…

Puerto Rico Limaris Alvarado, business director of PharmaLex Puerto Rico (formerly ECHO Consulting Group), started ECHO Consulting Group to enhance and maintain the education of healthcare industry professionals in Puerto Rico via expert resources with international and regulatory experience. After 17 years, the company is a renowned leader of validation, quality and…

Rankings The MEA market has reached $25B in value, growing at 8% CAGR; short term growth stood at 10% from 2017 to 2018. Saudi Arabia, the largest market in MEA at $8.2B in value, grew at 7% in value terms. Egypt, Algeria and UAE are other large markets that had double-digit…

MEA These 10 corporations represent 37% of the MEA market by value. Novo Nordisk’s USD 635M growth is mainly driven by Norditropin (somatropin), Victoza (liraglutide) & Saxenda (liraglutide) which have grown at 60%, 18% and 190% PPG respectively. Hikma’s USD 497M growth has been the fastest due to Remox (amoxicillin) and…

Algeria Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management.   Noncommunicable diseases are a growing burden in Algeria. The results of a STEPwise survey revealed that, for adults aged between 18 and 69 years, 23.6…

Taiwan United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform capabilities. Chang Yi Wang is the Chairperson and CSO of United BioPharma (UBP), a member of the UBI group of…

Pharma Faces 2019 saw Boehringer Ingelheim (BI) veteran Felix Gutsche take up his first country manager role – of a top-three affiliate, no less – after blazing a rather unorthodox path. From an International Trainee role at BI HQ, he moved into finance, where he stayed for a decade, with stints in…

Puerto Rico A long list of multinational pharma companies count Puerto Rico as one of their top manufacturing bases, including 11 of the top 20 global pharma companies. Puerto Rico also manufactures half of the 2018 world’s top 10 bestselling drugs, underscoring the fact that the island is a pharma production powerhouse.…

Sweden Karo Pharma is a Swedish specialty pharma company that develops and markets products to pharmacies and healthcare providers. CEO Christoffer Lorenzen discusses the company’s growth strategy through acquisitions of trusted well-positioned brands, the challenge of incorporating two similar-sized companies, and his high ambitions for the future of Karo Pharma.  …

Opinion Dr Valters Bolevics, CEO of the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) in Latvia, gives an overview of recent market changes affecting the Latvian pharmaceutical market, regulatory upgrades, and growth projections for 2020.   Following a breakthrough year in 2018, 2019 has also seen numerous positive changes for the…